Caprotec Bioanalytics Appoints Dr. Jonathan Turner as Managing Director and Chief Executive Officer
10/19/2012 10:10:28 AM
More...
|
Caprotec Bioanalytics Announces Further Patent Protection of its CCMS Technology
2/8/2012 9:57:51 AM
More...
|
Caprotec Bioanalytics Discovers Novel Drug-Protein Interactions of Three Anti-Cancer Drugs Using Its CCMS Technology
12/8/2011 10:01:42 AM
More...
|
Caprotec Bioanalytics Announces Collaborative Research Agreement With Bayer CropScience AG
12/6/2011 9:15:13 AM
More...
|
Caprotec Bioanalytics Increases Series B Financing in Second Closing to EUR 5 Million
5/9/2011 8:32:44 AM
More...
|
Caprotec Bioanalytics Announces Issuance In Europe of All Core Patents of Its CCMS Technology
2/28/2011 9:41:20 AM
More...
|
Caprotec Bioanalytics Appoints Prof. Dr. Rainer Metternich as Managing Director, Chief Business Officer and Chief Operating Officer
10/4/2010 10:07:50 AM
More...
|
Caprotec Bioanalytics Announces Commercial Launch of Three New caproKits(TM) for Applications in Functional Proteomics and Drug Development
10/1/2010 8:12:16 AM
More...
|
Caprotec Bioanalytics Announces the Successful Completion of a Collaborative Research Project With Roche (RHHBY)
6/29/2010 11:08:34 AM
More...
|
Caprotec Bioanalytics Closes $5M Funding Round
5/14/2010 8:36:36 AM
More...
|
|